ENSYSCE BIOSCIENCES, INC. Gain (Loss) on Disposition of Assets
ENSYSCE BIOSCIENCES, INC. (ENSC) reported Gain (Loss) on Disposition of Assets of $4.50 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-03-15
- ENSYSCE BIOSCIENCES, INC. gain (loss) on disposition of assets for the quarter ending 2022-12-31 was $0.00.
- ENSYSCE BIOSCIENCES, INC. gain (loss) on disposition of assets for the quarter ending 2022-09-30 was $0.00.
- ENSYSCE BIOSCIENCES, INC. gain (loss) on disposition of assets for the quarter ending 2022-06-30 was $0.00.
- ENSYSCE BIOSCIENCES, INC. gain (loss) on disposition of assets for the quarter ending 2022-03-31 was $4.50K.
- ENSYSCE BIOSCIENCES, INC. gain (loss) on disposition of assets for fiscal 2022 was $4.50K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $0.00 derived: sum of 3 quarters · filed 2024-03-15 | $4.50K 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $4.50K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $4.50K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $4.50K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |